AGC Biologics to Manufacture AAVantgardes Dual-Vector Gene Therapies for Inherited Retinal Disorders
Partnership accelerates AGC Biologics' leadership in the AAV market, applying its BravoAAV™…
Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
SHANGHAI--(BUSINESS WIRE)--Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd.…